Can the Acute-Phase Reactant Proteins be Used as Cancer Biomarkers?

  • Wei Wei Pang
    University of Malaya Centre for Proteomics Research, University of Malaya, Kuala Lumpur - Malaysia
  • Puteri Shafinaz Abdul-Rahman
    University of Malaya Centre for Proteomics Research, University of Malaya, Kuala Lumpur - Malaysia
  • Wan Izlina Wan-Ibrahim
    Department of Molecular Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur - Malaysia
  • Onn Haji Hashim
    University of Malaya Centre for Proteomics Research, University of Malaya, Kuala Lumpur - Malaysia

書誌事項

公開日
2010-01
権利情報
  • https://journals.sagepub.com/page/policies/text-and-data-mining-license
DOI
  • 10.1177/172460081002500101
公開者
SAGE Publications

この論文をさがす

説明

<jats:p>The association between the acute-phase reactant proteins (APRPs) and cancer has long been established. There have been numerous reports correlating altered levels of various APRPs with different types of cancers. However, researchers are often quick to dismiss the use of these APRPs as potential biomarkers for the diagnosis and monitoring of cancer because alterations in APRP concentrations are observed in a wide range of diseases. Recent progress in proteomics studies which profiled the serum proteins of cancer patients and those of normal individuals indicated that the altered APRP expressions were different for distinct types, subtypes, and even stages of cancer. Interestingly, these data are in agreement with those observed earlier using immunochemical and biochemical assays. In view of this compelling association of different patterns of APRPs with various types of cancers and in an apparent shift of paradigm, we present in this review some indications that APRP fingerprinting may be used as complementary cancer biomarkers.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ